Treatment Details - 17.8 months | Surviving Mesothelioma

Treatment Details – 17.8 months

Survival: 17.8 months
Toxicity Grade: 5
Treatments: Biologic therapy
Drugs: IFEX
Country: Germany
City/State/Province: Lubeck
Hospital: Medical University of Lubeck
Journal: Link
Date: 3/2003

Patients: This Phase II study involved 27 patients with advanced malignant pleural mesothelioma.

Treatment: The treatment consisted of a combination of hyperthermia with three chemotherapy drugs – ifosfamide (IFEX), carboplatin (paraplatin), and etoposide (vepesid).

Toxicity: There was one death associated with progressive disease and sepsis. Other toxicities included hematologic (grades 1-4), gastrointestinal (grades 1-3), nausea and vomiting (grades 1-3), hepatic (grades 1-2), skin (grade 3), and renal (grades 1-2). In addition, there were two cardiac complications during hyperthermia.

Results: Median survival was 76.6 weeks (17.8 months).

Correspondence: A.Bakhshandeh, MD

Get your free copy of
“Surviving Mesothelioma” Today!